0001120478-26-000013.txt : 20260424 0001120478-26-000013.hdr.sgml : 20260424 20260424161914 ACCESSION NUMBER: 0001120478-26-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260423 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD CENTRAL INDEX KEY: 0001120478 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42279 FILM NUMBER: 26894346 MAIL ADDRESS: STREET 1: C/O BIOAGE LABS, INC. STREET 2: 5885 HOLLIS STREET, SUITE 370 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioAge Labs, Inc. CENTRAL INDEX KEY: 0001709941 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 474721157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET STREET 2: SUITE 370 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-806-1445 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET STREET 2: SUITE 370 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 form4-04242026_080410.xml X0609 4 2026-04-23 0001709941 BioAge Labs, Inc. BIOA 0001120478 GOLDSTEIN DOV A MD false C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370 EMERYVILLE CA 94608 false true false false Chief Financial Officer 0 Common Stock 2026-04-23 4 M 0 3542 4.38 A 36575 D Stock Option (Right to Buy) 4.38 2026-04-23 4 M 0 3542 0 D 2035-02-17 Common Stock 3542 155833 D The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. /s/ Dov A. Goldstein 2026-04-24